Awareness of isotretinoin use and safety in Saudi Arabia: A nationwide cross-sectional study

被引:2
作者
Alshehri, Abdullah A. [1 ]
Althobaiti, Bander A. [2 ,3 ]
Khawagi, Wael Y. [1 ]
Murphy, Kevin D. [2 ]
机构
[1] Taif Univ, Coll Pharm, Dept Clin Pharm, Taif 26571, Saudi Arabia
[2] Univ Coll Cork, Sch Pharm, Pharmaceut Care Res Grp, Cork, Ireland
[3] King Abduaziz Specialised Hosp, Minist Hlth, Taif, Saudi Arabia
关键词
Medication Safety; Awareness; Isotretinoin; Saudi Arabia; Cross-sectional study; ACNE; MANAGEMENT;
D O I
10.1016/j.jsps.2023.101796
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Acne is a prevalent skin condition that affects numerous adolescents and adults worldwide. The most effective treatment for acne is isotretinoin, but its usage is associated with a wide range of adverse effects, and regular monitoring is necessary. Hence, appropriate usage with awareness of potential side effects is crucial. This study aimed to assess the knowledge and awareness of isotretinoin use and safety among individuals with acne in Saudi Arabia.Methods: A national cross-sectional survey was conducted through an online self-administered questionnaire distributed via social media platforms. The questionnaire consisted of 27 questions in multiplechoice and Likert scale formats, covering demographics, patient awareness of isotretinoin use and side effects, satisfaction with clinical consultation and information provided. Descriptive statistics were used to summarize data.Results: 1315 participants completed the survey, of which most were female (74.1%), single (67.5%), and aged 18-25 years (48.9%). Dryness and teratogenicity were the most commonly known side effects of isotretinoin use (85.5% and 64.9% respectively). However, most participants were unaware of other side effects, such as psychiatric disorders (62.9%), altered liver enzyme concentrations (65.2%), hyperlipidemia (68.1%), anemia (92.4%), and decreased platelet count (96%). Moreover, 36% of sexually active females initiated isotretinoin without contraception. Regarding satisfaction with the information provided during clinical consultation, 63.2% of participants were very satisfied or satisfied. Doctors were the primary source of information (86.8%), followed by the internet (17.8%). Only 45% were informed to avoid blood donation during and after treatment for at least two months.Conclusion: The study highlights the significance of providing patients with comprehensive information about the potential side effects of isotretinoin, including the need to use contraception and avoid blood donation during and after treatment. Effective communication between physicians and patients is critical in ensuring the safe and effective use of isotretinoin.(c) 2023 The Author(s). Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页数:6
相关论文
共 15 条
[1]   Females' Knowledge and Use of Isotretinoin (Roaccutane) in the Western Region of Saudi Arabia [J].
Bakheet, Kholoud Mohammed A. ;
Alghanemi, Rand G. ;
Alsiyoufi, Alya M. ;
Abduljabbar, Mohammed ;
Hariri, Jehad .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (12)
[2]   Epidemiology of acne vulgaris [J].
Bhate, K. ;
Williams, H. C. .
BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (03) :474-485
[3]   Adverse effects of isotretinoin: A large, retrospective review [J].
Brzezinski, Piotr ;
Borowska, Katarzyna ;
Chiriac, Anca ;
Smigielski, Janusz .
DERMATOLOGIC THERAPY, 2017, 30 (04)
[4]  
Charakida A, 2004, Expert Opin Drug Saf, V3, P119, DOI 10.1517/eods.3.2.119.27340
[5]   Management of Acne Vulgaris [J].
Eichenfield, Dawn Z. ;
Sprague, Jessica ;
Eichenfield, Lawrence F. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (20) :2055-2067
[6]   Patients' Knowledge and Information Needs about Isotretinoin Therapy Use in Jordan [J].
Jarab, Anan S. ;
Al-Azzam, Sayer ;
Almutairi, Shriefa ;
Mukattash, Tareq L. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2022, 2022 :9443884
[7]  
Kang Liyang, 2015, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V40, P1115, DOI 10.11817/j.issn.1672-7347.2015.10.010
[8]   The use of isotretinoin in acne [J].
Layton, Alison .
DERMATO-ENDOCRINOLOGY, 2009, 1 (03) :162-169
[9]   Laboratory Monitoring During Isotretinoin Therapy for Acne A Systematic Review and Meta-analysis [J].
Lee, Young H. ;
Scharnitz, Thomas P. ;
Muscat, Joshua ;
Chen, Allshine ;
Gupta-Elera, Gaytri ;
Kirby, Joslyn S. .
JAMA DERMATOLOGY, 2016, 152 (01) :35-44
[10]   Analysis of common side effects of isotretinoin [J].
McLane, J .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 45 (05) :S188-S194